Filing Flows › BillionToOne (BLLN) › Oncology revenue
BillionToOne (BLLN) Oncology revenue by quarter
BillionToOne's Oncology revenue was $17.1M in Q3 2026 (third quarter 2026), +25% from Q2 2026. Over the last 5 quarters it ranged from $8.7M (Q3 2025) to $17.1M (Q3 2026).
| Quarter | Oncology revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $17.1M | +25% | +96% |
| Q2 2026 | $13.7M | +27% | — |
| Q1 2026 | $10.7M | +17% | — |
| Q4 2025 | $9.1M | +5% | — |
| Q3 2025 | $8.7M | — | — |
Q3 2026 at a glance
BillionToOne, Q3 2026: revenue $123M (+47% year over year), operating margin 9.0%, net earnings $17.4M, operating cash flow $12.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is BillionToOne's Oncology revenue?
BillionToOne's Oncology revenue was $17.1M in Q3 2026 (third quarter 2026), +25% from Q2 2026.
How has BillionToOne's Oncology revenue changed?
Over the last 5 quarters it ranged from $8.7M (Q3 2025) to $17.1M (Q3 2026).